Kiener Peter A
Related Filers (4)
- Sucampo Pharmaceuticals, Inc. (15)
- Cue Biopharma, Inc. (11)
- PIERIS PHARMACEUTICALS, INC. (8)
- MEDIMMUNE INC /DE (4)
- Show More ...
Ownership (38)
4
Thursday, 1/4/2024
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
PIERIS PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 3/27/2023
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
PIERIS PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/5/2022
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/17/2021
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/29/2021
PIERIS PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/6/2021
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/25/2020
PIERIS PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/28/2020
PIERIS PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 1/6/2020
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/29/2019
PIERIS PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/3/2019
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/25/2018
PIERIS PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Friday, 9/14/2018
PIERIS PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
4
Thursday, 6/14/2018
Cue Biopharma, Inc.: Statement of changes in beneficial ownership of securities
3/A
Tuesday, 2/13/2018
Cue Biopharma, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/13/2018
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2018
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/2/2018
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 12/27/2017
Cue Biopharma, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 12/11/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/5/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/8/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/6/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/21/2016
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/18/2016
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2016
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/4/2016
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/13/2015
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 3/13/2015
Sucampo Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 2/27/2006
MEDIMMUNE INC /DE: Statement of changes in beneficial ownership of securities
4
Thursday, 2/9/2006
MEDIMMUNE INC /DE: Statement of changes in beneficial ownership of securities
3/A
Friday, 9/9/2005
MEDIMMUNE INC /DE: Initial statement of beneficial ownership of securities
3
Tuesday, 5/31/2005
MEDIMMUNE INC /DE: Initial statement of beneficial ownership of securities